|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02877 SHINEWAY PHARM
Nominal 
7.570 -0.170 (-2.196%) Ranking Overview
Ranking based on 2 research report(s)
Average Ranking 2.50
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
1
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 111.00 RMB (cts) | |
| Net Profit | 840.05 RMB (MIL) | DPS | 54.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 971.50 | 122.25 | 52.51 | -- | 1,113.00 | 830.00 |
| 2026 | 1,091.55 | 137.35 | 58.81 | -- | 1,240.00 | 943.10 |
| 2027 | 1,063.10 | 140.70 | 59.84 | -- | 1,063.10 | 1,063.10 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 1,113.00 | 134.60 | 57.90 | CCBI | OutPerform | 10.00 | 13/11/2024 | |
| 2025 | 830.00 | 109.90 | 47.12 | UOB | Hold | 8.50 | 31/03/2025 | |
| 2026 | 1,240.00 | 149.90 | 64.50 | CCBI | -- | -- | 13/11/2024 | |
| 2026 | 943.10 | 124.80 | 53.11 | UOB | -- | -- | 31/03/2025 | |
| 2027 | 1,063.10 | 140.70 | 59.84 | UOB | -- | -- | 31/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 16/04/2025 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 840,052 |
| %Change | -13.353% |
| EPS / (LPS) | RMB 1.110 |
| NBV Per Share (¥) | RMB 9.029 |